These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 16449476)

  • 1. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
    Leverich GS; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Kupka RW; Denicoff KD; Nolen WA; Grunze H; Martinez MI; Post RM
    Am J Psychiatry; 2006 Feb; 163(2):232-9. PubMed ID: 16449476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers.
    Post RM; Altshuler LL; Frye MA; Suppes T; Rush AJ; Keck PE; McElroy SL; Denicoff KD; Leverich GS; Kupka R; Nolen WA
    Bipolar Disord; 2001 Oct; 3(5):259-65. PubMed ID: 11912569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
    Post RM; Altshuler LL; Leverich GS; Frye MA; Nolen WA; Kupka RW; Suppes T; McElroy S; Keck PE; Denicoff KD; Grunze H; Walden J; Kitchen CM; Mintz J
    Br J Psychiatry; 2006 Aug; 189():124-31. PubMed ID: 16880481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
    Altshuler LL; Post RM; Hellemann G; Leverich GS; Nolen WA; Frye MA; Keck PE; Kupka RW; Grunze H; McElroy SL; Sugar CA; Suppes T
    J Clin Psychiatry; 2009 Apr; 70(4):450-7. PubMed ID: 19358785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.
    Post RM; Leverich GS; Nolen WA; Kupka RW; Altshuler LL; Frye MA; Suppes T; McElroy S; Keck P; Grunze H; Walden J;
    Bipolar Disord; 2003 Dec; 5(6):396-406. PubMed ID: 14636363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-induced mania in bipolar patients: identification of risk factors.
    Henry C; Sorbara F; Lacoste J; Gindre C; Leboyer M
    J Clin Psychiatry; 2001 Apr; 62(4):249-55. PubMed ID: 11379838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
    Vieta E; Martinez-Arán A; Goikolea JM; Torrent C; Colom F; Benabarre A; Reinares M
    J Clin Psychiatry; 2002 Jun; 63(6):508-12. PubMed ID: 12088162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.
    Altshuler LL; Suppes T; Black DO; Nolen WA; Leverich G; Keck PE; Frye MA; Kupka R; McElroy SL; Grunze H; Kitchen CM; Post R
    Am J Psychiatry; 2006 Feb; 163(2):313-5. PubMed ID: 16449487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.
    Frye MA; Helleman G; McElroy SL; Altshuler LL; Black DO; Keck PE; Nolen WA; Kupka R; Leverich GS; Grunze H; Mintz J; Post RM; Suppes T
    Am J Psychiatry; 2009 Feb; 166(2):164-72. PubMed ID: 19015231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
    Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
    J Affect Disord; 2015 Oct; 185():31-7. PubMed ID: 26143402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bipolar depression and antidepressant-induced mania: a naturalistic study.
    Boerlin HL; Gitlin MJ; Zoellner LA; Hammen CL
    J Clin Psychiatry; 1998 Jul; 59(7):374-9. PubMed ID: 9714266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms.
    Chen J; Fang Y; Kemp DE; Calabrese JR; Gao K
    Curr Psychiatry Rep; 2010 Dec; 12(6):512-21. PubMed ID: 20878507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
    Ghaemi SN; Ostacher MM; El-Mallakh RS; Borrelli D; Baldassano CF; Kelley ME; Filkowski MM; Hennen J; Sachs GS; Goodwin FK; Baldessarini RJ
    J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Expert Consensus Guidelines for treating depression in bipolar disorder.
    Frances AJ; Kahn DA; Carpenter D; Docherty JP; Donovan SL
    J Clin Psychiatry; 1998; 59 Suppl 4():73-9. PubMed ID: 9554324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder.
    Gao K; Kemp DE; Ganocy SJ; Muzina DJ; Xia G; Findling RL; Calabrese JR
    Bipolar Disord; 2008 Dec; 10(8):907-15. PubMed ID: 19594506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression.
    Yatham LN; Arumugham SS; Kesavan M; Ramachandran K; Murthy NS; Saraf G; Ouyang Y; Bond DJ; Schaffer A; Ravindran A; Ravindran N; Frey BN; Daigneault A; Beaulieu S; Lam RW; Kondapuram N; Reddy MS; Bhandary RP; Ashok MV; Ha K; Ahn YM; Milev R; Wong H; Reddy YCJ;
    N Engl J Med; 2023 Aug; 389(5):430-440. PubMed ID: 37530824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switch Rates During Acute Treatment for Bipolar II Depression With Lithium, Sertraline, or the Two Combined: A Randomized Double-Blind Comparison.
    Altshuler LL; Sugar CA; McElroy SL; Calimlim B; Gitlin M; Keck PE; Aquino-Elias A; Martens BE; Fischer EG; English TL; Roach J; Suppes T
    Am J Psychiatry; 2017 Mar; 174(3):266-276. PubMed ID: 28135846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion as add-on strategy in difficult-to-treat bipolar depressive patients.
    Erfurth A; Michael N; Stadtland C; Arolt V
    Neuropsychobiology; 2002; 45 Suppl 1():33-6. PubMed ID: 11893875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Truman CJ; Goldberg JF; Ghaemi SN; Baldassano CF; Wisniewski SR; Dennehy EB; Thase ME; Sachs GS
    J Clin Psychiatry; 2007 Oct; 68(10):1472-9. PubMed ID: 17960960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.